SLC31A1 and lung cancer: The results shown that the combined treatment inhibits the growth of tumors in animal lung cancer models, reduces the expression of Ki-67, and promotes the capture of CDDP in lung cancer cell lines, confirming that the positive regulation of CTR1 expression is a mechanism that promotes chemosensitization to CDDP [65].